Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...

Sales in the Pharmaceuticals Division were up 8% in the first quarter to CHF 11.9 billion, owing to strong growth in demand for key drugs like Phesgo (breast cancer), Vabysmo (severe eye diseases ...

In a FOX Carolina investigation, Margaret-Ann Carter finds out how it could make the difference between life and death for many. House Bill 3591 is a Fentanyl Induced Homicide law, meaning, it would ...

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).